Page last updated: 2024-10-26

valproic acid and Carcinoma, Medullary

valproic acid has been researched along with Carcinoma, Medullary in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenblatt, DY1
Cayo, MA1
Adler, JT1
Ning, L1
Haymart, MR1
Kunnimalaiyaan, M1
Chen, H1

Other Studies

1 other study available for valproic acid and Carcinoma, Medullary

ArticleYear
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Annals of surgery, 2008, Volume: 247, Issue:6

    Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcin

2008